Premalignant lesions serve as critical transitional states in the development of many cancers. They also provide a scientific basis for the traditional Chinese medicine (TCM) concept of “treating ...

Natera recently reported a series of advances, including an upgraded multi-modal Signatera MRD model, expanded AI ...

In today’s fast-moving biopharma landscape, companies face increasing pressure to deliver the right treatment, to the right patient, at the right time, faster and more efficiently. As our ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...

Effect of baseline geriatric and quality of life assessments on treatment outcomes in ECOG-ACRIN EA2186 (GIANT): A randomized phase II study of gemcitabine and nab-paclitaxel compared with ...

Natera NTRA recently announced a collaboration with NVIDIA NVDA to speed up the development of its multimodal AI foundation ...

BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...

New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence risk in ...

Lung cancer is one of the most challenging diseases, making early diagnosis crucial for effective treatment. Fortunately, advancements in artificial intelligence (AI) are transforming lung cancer ...

The integration of artificial intelligence (AI) with imaging has emerged as a transformative force in the field of oral oncology. Oral cancer remains a ...